{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:34:45Z","timestamp":1786696485361,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.talanta.2026.130129","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:19:58Z","timestamp":1781457598000},"page":"130129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["New chemotherapeutic strategies against mesenchymal triple-negative breast cancer: A deeper look at the molecular level"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4477-6794","authenticated-orcid":false,"given":"Clara B.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.M.","family":"Batista de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vojtek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8391-0055","authenticated-orcid":false,"given":"Maria P.M.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-8537","authenticated-orcid":false,"given":"Lu\u00eds A.E.","family":"Batista de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.talanta.2026.130129_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"issue":"5","key":"10.1016\/j.talanta.2026.130129_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12282-024-01597-z","article-title":"Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype","volume":"31","author":"Jezequel","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.talanta.2026.130129_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ctrv.2017.11.003","article-title":"Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies","volume":"62","author":"Lee","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.talanta.2026.130129_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.talanta.2026.130129_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"17","key":"10.1016\/j.talanta.2026.130129_bib6","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/cancers14174280","article-title":"Challenges for triple negative breast cancer treatment: defeating heterogeneity and cancer stemness","volume":"14","author":"Mahmoud","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.talanta.2026.130129_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.talanta.2026.130129_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.770663","article-title":"Platinum and taxane based adjuvant and neoadjuvant chemotherapy in early triple-negative breast cancer: a narrative review","volume":"12","author":"Tian","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.talanta.2026.130129_bib9","first-page":"15","article-title":"Treatment strategies against triple-negative breast cancer: an updated review","volume":"14","author":"Maqbool","year":"2022","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.talanta.2026.130129_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.20892\/j.issn.2095-3941.2021.0529","article-title":"Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis","volume":"19","author":"Li","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.talanta.2026.130129_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1157306","article-title":"Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: Paclitaxel, docetaxel, and cabazitaxel","volume":"14","author":"Sousa-Pimenta","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.talanta.2026.130129_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovic","year":"2019","journal-title":"Cells"},{"issue":"5191","key":"10.1016\/j.talanta.2026.130129_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.talanta.2026.130129_bib14","first-page":"106","article-title":"Selected platinum complexes in standard and modern anti-cancer therapies","volume":"7","author":"Kopacz-Bednarska","year":"2022","journal-title":"Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory"},{"issue":"29","key":"10.1016\/j.talanta.2026.130129_bib15","doi-asserted-by":"crossref","DOI":"10.1039\/D2DT01875F","article-title":"A chemical perspective on the clinical use of platinum-based anticancer drugs","volume":"51","author":"Alassadi","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.talanta.2026.130129_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1039\/C5FD00148J","article-title":"Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy","volume":"187","author":"Batista de Carvalho","year":"2016","journal-title":"Faraday Discuss."},{"issue":"4","key":"10.1016\/j.talanta.2026.130129_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/pharmaceutics15041205","article-title":"Pd(II) and Pt(II) trinuclear chelates with spermidine: selective anticancer activity towards TNBC-sensitive and -Resistant to cisplatin","volume":"15","author":"Vojtek","year":"2023","journal-title":"Pharmaceutics"},{"issue":"27","key":"10.1016\/j.talanta.2026.130129_bib18","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.5c02233","article-title":"New chemotherapeutic approaches to treatment of mesenchymal triple-negative breast cancer-sensitive and resistant to cisplatin: assessment of cellular response by vibrational microspectroscopy","volume":"97","author":"Martins","year":"2025","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2026.130129_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/biomedicines10020210","article-title":"Pd2Spermine complex shows cancer selectivity and efficacy to inhibit growth of triple-negative breast tumors in mice","volume":"10","author":"Vojtek","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.talanta.2026.130129_bib20","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1039\/C5NJ01088H","article-title":"Conformational insights and vibrational study of a promising anticancer agent: the role of the ligand in pd(ii)\u2013amine complexes","volume":"39","author":"Fiuza","year":"2015","journal-title":"New J. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2026.130129_bib21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/molecules28041698","article-title":"A non-conventional platinum drug against a non-small cell lung cancer line","volume":"28","author":"Silva","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.talanta.2026.130129_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/0144235X.2020.1700083","article-title":"Intracellular water as a mediator of anticancer drug action","volume":"39","author":"Marques","year":"2020","journal-title":"Int. Rev. Phys. Chem."},{"issue":"5","key":"10.1016\/j.talanta.2026.130129_bib23","doi-asserted-by":"crossref","DOI":"10.1063\/4.0000021","article-title":"Role of intracellular water in the normal-to-cancer transition in human cells-insights from quasi-elastic neutron scattering","volume":"7","author":"Marques","year":"2020","journal-title":"Struct. Dyn."},{"issue":"1","key":"10.1016\/j.talanta.2026.130129_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47649-w","article-title":"Cellular dynamics as a marker of normal-to-cancer transition in human cells","volume":"13","author":"Marques","year":"2023","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.talanta.2026.130129_bib25","doi-asserted-by":"crossref","DOI":"10.1364\/AO.57.000E11","article-title":"Advancing Raman microspectroscopy for cellular and subcellular analysis: towards in vitro high-content spectralomic analysis","volume":"57","author":"Byrne","year":"2018","journal-title":"Appl. Opt."},{"issue":"9","key":"10.1016\/j.talanta.2026.130129_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500814","article-title":"Triple-negative breast cancer versus non-triple-negative breast cancer: the impact of Pd and Pt complexes on basal-like triple-negative breast cancer","volume":"21","author":"Martins","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.talanta.2026.130129_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.infrared.2018.11.026","article-title":"Infrared microscopy in the study of cellular biochemistry","volume":"105","author":"Quaroni","year":"2020","journal-title":"Infrared Phys. Technol."},{"issue":"2","key":"10.1016\/j.talanta.2026.130129_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cancers14020452","article-title":"Who's who? Discrimination of human breast cancer cell lines by raman and FTIR microspectroscopy","volume":"14","author":"Santos","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.talanta.2026.130129_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/bios13050557","article-title":"Molecular fingerprint detection using raman and infrared spectroscopy technologies for cancer detection: a progress review","volume":"13","author":"Zhang","year":"2023","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.talanta.2026.130129_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0162-0134(92)80037-V","article-title":"Palladium(II) salt and complexes of spermidine with a six-member chelate ring. Synthesis, characterization, and initial DNA-binding and antitumor studies","volume":"46","author":"Navarro-Ranninger","year":"1992","journal-title":"J. Inorg. Biochem."},{"issue":"18","key":"10.1016\/j.talanta.2026.130129_bib31","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/ic00317a005","article-title":"Chemistry of Bis(platinum) complexes. Formatin of trans derivatives from tetraamine complexes","volume":"28","author":"Farrell","year":"1989","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.talanta.2026.130129_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for ellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.talanta.2026.130129_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1039\/c2an16088a","article-title":"FTIR microscopy of biological cells and tissue: data analysis using resonant Mie scattering (RMieS) EMSC algorithm","volume":"137","author":"Bassan","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2026.130129_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/649640","article-title":"Sensitive marker of the Cisplatin-DNA interaction: X-ray photoelectron spectroscopy of CL","volume":"2012","author":"Xiao","year":"2012","journal-title":"Bioinorgan. Chem. Appl."},{"issue":"7","key":"10.1016\/j.talanta.2026.130129_bib35","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1039\/C4CP05183A","article-title":"A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance","volume":"17","author":"Marques","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"8","key":"10.1016\/j.talanta.2026.130129_bib36","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1039\/C4DT03237C","article-title":"Solution studies on DNA interactions of substitution-inert platinum complexes mediated via the phosphate clamp","volume":"44","author":"Qu","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.talanta.2026.130129_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ica.2016.04.052","article-title":"The phosphate clamp as recognition motif in platinum\u2013DNA interactions","volume":"452","author":"Komeda","year":"2016","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.talanta.2026.130129_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fchem.2019.00307","article-title":"TriplatinNC and biomolecules: building models based on non-covalent interactions","volume":"7","author":"Rosa","year":"2019","journal-title":"Front. Chem."},{"issue":"7","key":"10.1016\/j.talanta.2026.130129_bib39","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"20","key":"10.1016\/j.talanta.2026.130129_bib40","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1002\/slct.202001361","article-title":"Cytotoxicity of platinum and palladium chelates against osteosarcoma","volume":"5","author":"Martins","year":"2020","journal-title":"ChemistrySelect"},{"issue":"4","key":"10.1016\/j.talanta.2026.130129_bib41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/cancers13040669","article-title":"Drug combination in cancer treatment-from cocktails to conjugated combinations","volume":"13","author":"Gilad","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.talanta.2026.130129_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.124389","article-title":"Vibrational microspectroscopy as a tool to unveil new chemotherapeutic strategies against osteosarcoma","volume":"317","author":"Laginha","year":"2024","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"1","key":"10.1016\/j.talanta.2026.130129_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bip.20167","article-title":"Fixation protocols for subcellular imaging by synchrotron-based Fourier transform infrared microspectroscopy","volume":"77","author":"Gazi","year":"2005","journal-title":"Biopolymers"},{"issue":"8","key":"10.1016\/j.talanta.2026.130129_bib47","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/nprot.2014.110","article-title":"Using Fourier transform IR spectroscopy to analyze biological materials","volume":"9","author":"Baker","year":"2014","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.talanta.2026.130129_bib48","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s00216-010-3759-8","article-title":"Raman spectral imaging of single cancer cells: probing the impact of sample fixation methods","volume":"397","author":"Draux","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2026.130129_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updates"},{"issue":"4","key":"10.1016\/j.talanta.2026.130129_bib50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-An agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402600785X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402600785X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:25:39Z","timestamp":1786695939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003991402600785X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S003991402600785X"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130129","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New chemotherapeutic strategies against mesenchymal triple-negative breast cancer: A deeper look at the molecular level","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130129"}}